Takeda logo

Director/PDMR Share Dealings

Director/PDMR Share Dealings


Calendar
March 30, 2014

Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that today Ordinary Shares (“Shares”) and American Depository Shares (“ADSs”) of the Company, as set out below, have been acquired for the Non-Executive Directors, being the part of their total fees that are paid in securities for the period of service from January 1 to March 31, 2014.

  Type of Security (1)Number of Securities
 Dominic Blakemore Shares 147
 William Burns Shares 178
 Dr. Steven Gillis ADSs 57
 Dr. David Ginsburg ADSs 54
 David Kappler Shares 186
 Susan Kilsby ADSs 61
 Anne Minto Shares 185
 David Stout ADSs 59

 

(1) One ADS is equql to three Shares

The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ respectively at prices of £29.9876 per Share and $147.90 per ADS.

This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.

Tony Guthrie

Deputy Company Secretary

For further information please contact:

Investor Relations

Laurie Stelzer
[email protected]
+1 781 482 0733

Eric Rojas
[email protected]
+1 781 482 0999

Sarah Elton-Farr
[email protected]
+44 1256 894157

Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.

www.shire.com

Click here for the PDF version of this press release.